Mucklow J C, Kuhn S
Br J Clin Pharmacol. 1985 Dec;20(6):589-96. doi: 10.1111/j.1365-2125.1985.tb05116.x.
The pharmacokinetics of four sustained-release formulations of theophylline have been examined after single doses (Nuelin SA, Phyllocontin, Slo-phyllin and Theo-Dur) and at steady-state (Phyllocontin, Theo-Dur) in six healthy adult volunteers, selected because they all eliminated theophylline rapidly after an intravenous dose of aminophylline. After a single dose of Theo-Dur, the peak concentration of theophylline was smaller and occurred later than after single doses of Nuelin SA, Phyllocontin and Slo-phyllin, suggesting that absorption occurs over a longer period. The systemic availability of theophylline was virtually complete after all four formulations. After repeated 12-hourly dosing to steady-state, and adjustment of dose to achieve trough concentrations of between 5 and 10 mg l-1 (28-55 mumol l-1), theophylline concentration fluctuated to a significantly greater extent within a dose interval when the subjects were taking Phyllocontin than when they were taking Theo-Dur.
在六名健康成年志愿者中,对四种茶碱缓释制剂(纽林控释片、菲洛康定、舒弗美和茶喘平)进行了单剂量(纽林控释片、菲洛康定、舒弗美和茶喘平)和稳态(菲洛康定、茶喘平)下的药代动力学研究。选择这些志愿者是因为他们在静脉注射氨茶碱后都能快速消除茶碱。单剂量服用茶喘平后,茶碱的峰值浓度低于单剂量服用纽林控释片、菲洛康定和舒弗美后的峰值浓度,且出现时间更晚,这表明吸收过程持续时间更长。所有四种制剂的茶碱全身利用率几乎都达到了100%。在每12小时重复给药至稳态,并调整剂量以使谷浓度达到5至10 mg l-1(28至55 μmol l-1)后,当受试者服用菲洛康定时,茶碱浓度在一个给药间隔内的波动幅度明显大于服用茶喘平时。